Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.31 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | ITGAL | P20701 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | ADK | P55263 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9819924 | 0.88 | MEN1 (0.39) | MEN1KMT2ATRPA1CA1CA2 | |
| SCHEMBL317047 | 0.74 | CDC25B (0.33) | MEN1KMT2ATSHR | |
| SCHEMBL286696 | 0.74 | TSHR (0.48) | TSHR | |
| SCHEMBL3884 | 0.74 | TSHR (0.48) | TSHR | |
| SCHEMBL29807605 | 0.73 | TSHR (0.58) | MEN1KMT2ATSHR | |
| SCHEMBL322056 | 0.73 | TSHR (0.58) | MEN1KMT2ATSHR | |
| SCHEMBL599885 | 0.73 | TSHR (0.50) | MEN1KMT2ATSHR | |
| SCHEMBL3868709 | 0.71 | ACHE (0.42) | MEN1KMT2ATSHRSLC6A2SLC6A3 | |
| SCHEMBL7166999 | 0.69 | TSHR (0.46) | MEN1KMT2ATSHR | |
| SCHEMBL5491066 | 0.69 | TSHR (0.52) | MEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3925989-A1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | Dow Global Technologies LLC (US) | 2021-12-22 | — | — | EP | claimed |
| CN-113201084-A | Molecular weight control of polyolefins using halogenated bisphenylphenoxy catalysts | 陶氏环球技术有限责任公司 | 2021-08-03 | — | — | CN | claimed |
| CN-106687486-B | Bis-biphenylphenoxy catalysts for polymerization of low molecular weight ethylene-based polymers | 陶氏环球技术有限责任公司 | 2021-03-19 | — | — | CN | claimed |
| EP-3578578-A1 | BIS-BIPHENYLPHENOXY CATALYSTS FOR POLYMERIZATION OF LOW MOLECULAR WEIGHT ETHYLENE-BASED POLYMERS | Dow Global Technologies Llc (US) | 2019-12-11 | — | — | EP | claimed |
| EP-2797963-B1 | HYPERBRANCHED OLEFIN OIL-BASED DIELECTRIC FLUID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-03 | — | — | EP | claimed |
| US-9975975-B2 | Bis-biphenylphenoxy catalysts for polymerization of low molecular weight ethylene-based polymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-05-22 | — | — | US | claimed |
| US-20170137550-A1 | BIS-BIPHENYLPHENOXY CATALYSTS FOR POLYMERIZATION OF LOW MOLECULAR WEIGHT ETHYLENE-BASED POLYMERS | DOW GLOBAL TECHNOLOGIES LLC | 2017-05-18 | — | — | US | claimed |
| US-9605098-B2 | Molecular weight control of polyolefins using halogenated bis-phenylphenoxy catalysts | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-03-28 | — | — | US | claimed |
| US-9601231-B2 | Hyperbranched olefin oil-based dielectric fluid | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-03-21 | — | — | US | claimed |
| US-9522855-B2 | Process for producing low molecular weight ethylene- and alpha-olefin-based materials | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-12-20 | — | — | US | claimed |
| EP-2491062-B1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-12-11 | — | — | EP | claimed |
| EP-2366704-B1 | Inhibitors of serine proteases | VERTEX PHARMA (US) | 2013-10-23 | — | — | EP | claimed |
| WO-2013101375-A1 | PROCESS FOR PRODUCING LOW MOLECULAR WEIGHT ETHYLENE- AND ALPHA-OLEFIN-BASED MATERIALS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-07-04 | — | — | WO | claimed |
| EP-2491062-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | Dow Global Technologies LLC (US) | 2012-08-29 | — | — | EP | claimed |
| WO-2011146044-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-11-24 | — | — | WO | claimed |
| WO-2011146291-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-11-24 | — | — | WO | claimed |
| US-20110282018-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC | 2011-11-17 | — | — | US | claimed |
| EP-0284359-B1 | 1,4-DISUBSTITUTED PIPERAZINE COMPOUNDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1992-01-08 | — | — | EP | claimed |
| US-4997836-A | Inhibitor of platelet activating factor | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-03-05 | — | — | US | claimed |
| US-4880809-A | HYPOTENSIVE AGENTS, AMIDE DERIVATIVES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-11-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282018-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | WEE2, NOTUM, WEE1 | MEN1 1052/4885KMT2A 3999/4885TSHR 4494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.